Pharmacological Preconditioning with Fenofibrate in Cardiomyocyte Cultures of Neonatal Rats Subjected to Hypoxia/Reoxygenation, High Glucose, and Their Combination
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111391 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Víctor Hugo Oidor-Chan und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Autonomous Metropolitan University, Iztapalapa Campus, Av. Ferrocarril de San Rafael Atlixco 186, Col. Leyes de Reforma …. Hauptthemen laut MEDLINE: Myocytes, Cardiac, Glucose, Apoptosis, Fenofibrate. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Pharmacological preconditioning is an alternative to protect the heart against the consequences of damage from ischemia/reperfusion (I/R). It is based on the administration of specific drugs that imitate the effect of ischemic preconditioning (IPC). Peroxisomal proliferator-activated receptors (PPARs) can prevent apoptosis in pathologies such as I/R and heart failure. Therefore, our objective was to determine if the stimulation of PPARα with fenofibrate (feno) decreases the apoptotic process induced by hypoxia/reoxygenation (HR), high glucose (HG), and HR/HG. For that purpose, cardiomyocyte cultures were divided into the following groups: Group 1—control (Ctrl); Group 2—HR; Group 3—HR + 10 μM feno; Group 4—HG, (25 mM glucose); Group 5—HG + feno; Group 6—HR/HG, and Group 7—HR/HG + feno. Our results indicate that cell viability decreases in neonatal cardiomyocytes undergoing HR, HG, and their combination, while feno improved cell viability. Feno treatment decreased apoptosis compared with HG-, HR-, or HG/HR-vehicle-treated. Nuclear- and mitochondrial-apoptosis markers increased in neonatal cardiomyocytes from HR, HG, and HR/HG; while the cytotoxicity decreased in cells treated with feno. In addition, the expression of Bax, Bad, and caspase 9 decreased due to feno, while 14-3-3ɛ and Bcl2 were increased. Inner mitochondrial cytochrome C increased with feno in every condition, as well as mitochondrial activity. Feno treatment prevented injury in the ultrastructure and in the mitochondrial membranes. Thus, our results suggest that feno decreases apoptosis in neonatal cardiomyocytes, improving the ultrastructure of mitochondria in the pathological conditions studied.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Autonomous Metropolitan University, Iztapalapa Campus, Av. Ferrocarril de San Rafael Atlixco 186, Col. Leyes de Reforma 1ª. Sección, Alcaldía Iztapalapa, Mexico City 09310, Mexico.
- Department of Pharmacobiology, Center for Research and Advanced Studies of the National Polytechnic Institute, Calz. de los Tenorios 235, Col Granjas Coapa, Tlalpan, Mexico City 14330, Mexico.
- Department of Physiology, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, Mexico.
- Department of Cardiovascular Biomedicine, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, Mexico.
- Department of Pharmacology, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, Mexico.
- Subdirection of Basic and Technological Research, National Institute of Cardiology Ignacio Chávez, Juan Badiano No. 1, Col. Sección XVI, Tlalpan, Mexico City 14080, Mexico.
ORCID-Profile: Víctor Hugo Oidor-Chan, Agustina Cano-Martinez, Willy Ramses García-Niño, Elizabeth Soria-Castro, Leonardo Del Valle-Mondragón, Mariana Patlán, Javier Flores-Estrada
Zitieren
APA
Oidor-Chan, V. H., Sánchez-López, A., Cano-Martinez, A., García-Niño, W. R., Soria-Castro, E., Del Valle-Mondragón, L., Zarco-Olvera, G., Patlán, M., Guarner-Lans, V., Rodríguez-Maldonado, E., Flores-Estrada, J., Castrejón-Téllez, V., & Ibarra-Lara, L. (2024). Pharmacological Preconditioning with Fenofibrate in Cardiomyocyte Cultures of Neonatal Rats Subjected to Hypoxia/Reoxygenation, High Glucose, and Their Combination. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111391
Vancouver
Oidor-Chan VH, Sánchez-López A, Cano-Martinez A, García-Niño WR, Soria-Castro E, Del Valle-Mondragón L, et al. Pharmacological Preconditioning with Fenofibrate in Cardiomyocyte Cultures of Neonatal Rats Subjected to Hypoxia/Reoxygenation, High Glucose, and Their Combination. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111391
BibTeX
@article{OidorChan2024,
author = {Oidor-Chan, Víctor Hugo and Sánchez-López, Araceli and Cano-Martinez, Agustina and García-Niño, Willy Ramses and Soria-Castro, Elizabeth and Del Valle-Mondragón, Leonardo and Zarco-Olvera, Gabriela and Patlán, Mariana and Guarner-Lans, Veronica and Rodríguez-Maldonado, Emma and Flores-Estrada, Javier and Castrejón-Téllez, Vicente and Ibarra-Lara, Luz},
title = {Pharmacological Preconditioning with Fenofibrate in Cardiomyocyte Cultures of Neonatal Rats Subjected to Hypoxia/Reoxygenation, High Glucose, and Their Combination},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111391}
}
EUVIMED